Abstract
Exhaled breath condensate (EBC) detection, as a new way of non-invasive studying pulmonary diseases, has advantages of being easily carried out, real-time monitoring, repeatability and better patients acceptance. Analying biomarkers in EBC which reflect airway inflammation and oxidative stress could assist in the diagnosis of obstructive sleep apnea syndrome (OSAS), the severity of this disease, and the evaluation of treatment. Identification of abnormal markers in EBC may provide new opinion on the pathogenesis of OSAS and new therapeutic. Key words: Exhaled breath condensate; Biomarkers; Obstructive sleep apnea syndrome
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have